Namibia has welcomed the price reductions for antiretroviral
drugs announced by Gilead Sciences and will consider buying drugs
from the firm. Gilead Sciences has announced it is ready to ship
its antiretroviral HIV drug Viread to every country in Africa and
to 15 other impoverished nations at US$1.30 a day for the once-a-day dose. Nonprofit organizations such as the Clinton Foundation,
started by former U.S. President Bill Clinton, and WHO will
subsidize the cost of the drugs. Health Permanent Secretary Dr.
Kalumbi Shangula said, "If the drug is according to our new
treatment protocol, we will buy it." Gilead said the US$1.30 fee
covers the cost of manufacturing the drug and administering a
program to process requests and quickly ship the drug directly to
eligible treatment programs in 53 African nations and 15 other
countries classified by the UN as least developed. The program
will be operational by the second quarter of this year.
Back to other CDC news for April 25, 2003